Bartolo Colon

Bartolo Colon’s success is really bothering some people

73 Comments

Bartolo Colon has pitched magnificently this season. He leads the AL in wins, is sporting a 2.89 ERA and is pounding the strike zone like crazy, allowing only one walk per every nine innings pitched. This, apparently, is something baseball should be embarrassed by. Why? Because he tested positive for synthetic testosterone last year  Paul Gackle of the San Francisco Examiner:

If the deadline for submitting the All-Star Game rosters were today, Colon should be a shoe-in to make the American League pitching staff, which would be colossal embarrassment for the commissioner’s office. It would suggest one of two things: PEDs don’t, in fact, enhance athletic performances, so what’s the big deal? Or he’s still cheating and he’s beating the system.

But let’s be clear here. Gackle is not seriously entertaining the former option:

Baseball wants us to believe that it’s capable of tidying up the sport, putting an end to the guessing game over who is cheating and who is clean. It caught Colon, Melky Cabrera and another 18 players connected to a Miami-area clinic, and those players reportedly could be suspended in the next few weeks. Colon’s season is, however, raising more doubt over whether testing can keep pace with the evolution of PEDs.

Let’s be clear, I’m not accusing Colon of cheating. He could be another rubber arm, like Nolan Ryan and Randy Johnson, as far as I’m concerned. But I will say that his performance is evidence that 50-game suspensions won’t cut it if baseball really wants to crack down on PED users.

No, he is accusing Colon of cheating. By definition he is, for the direct conclusion he draws from Colon’s success this year is that baseball’s drug testing doesn’t work and that Colon’s success is an embarrassment and then spends time comparing Colon to Pete Rose and the game-throwers of the Chicago Black Sox and proposes suspending players for two years for PEDs.

Look, I have no idea what Bartolo Colon is doing to be successful in 2013. But It’s not like he wasn’t a top-flight pitcher for many, many years before shoulder problems derailed him. A late-career bump — especially one that isn’t accompanied by some massive increase in velocity and an uptick in strikeout rates — is not anything historically unprecedented. The notion that he’s back on banned substances and eluding drug testing is not impossible, but it is an argument that requires more evidence than other possible explanations such as “good pitcher has good season” or “synthetic testosterone is not some magic super power-bestowing substance,” or “throwing pitches in the strike zone and relying on your defense is good strategy.”

Gackle has no interest in marshaling any such evidence, however. He, like so many others, is merely interested in turning a somewhat complex matter of science and biology, turning it into a matter of good and evil and thus taking the laziest possible approach in order to get his column inches in.

Report: Dexter Fowler will take a physical in St. Louis on Friday

CLEVELAND, OH - NOVEMBER 02:  Dexter Fowler #24 of the Chicago Cubs reacts after lining out during the third inning against the Cleveland Indians in Game Seven of the 2016 World Series at Progressive Field on November 2, 2016 in Cleveland, Ohio.  (Photo by Ezra Shaw/Getty Images)
Ezra Shaw/Getty Images
1 Comment

Update (8:27 PM EST): Derrick Goold of the St. Louis Post-Dispatch reports that the Cardinals made an “over-the-top offer” to Fowler to ensure he’d sign.

*

Frank Cusumano of KSDK Sports reports that free agent outfielder will take a physical in St. Louis on Friday. Presumably, that means that Fowler and the Cardinals have gotten pretty far along in negotiations.

Jon Heyman of FanRag Sports recently reported that Fowler was looking for $18 million per year. The Blue Jays reportedly made an offer to Fowler in the four-year, $16 million range several days ago. The Cardinals’ offer to Fowler, if there is indeed one, is likely somewhere between the two figures.

Fowler, 30, is coming off of a fantastic year in which he helped the Cubs win their first World Series since 1908. During the regular season, he hit .276/.393/.447 with 13 home runs, 48 RBI, 84 runs scored, and 13 stolen bases in 551 plate appearances.

Fowler rejected the Cubs’ $17.2 million qualifying offer last month. While the QO compensation negatively affected Fowler’s experience in free agency last offseason — he didn’t sign until late February with the Cubs — his strong season is expected to make QO compensation much less of an issue.

Braves acquire Luke Jackson from the Rangers

ARLINGTON, TX - SEPTEMBER 16:  Relief pitcher Luke Jackson #53 of the Texas Rangers  throws during the ninth inning of a baseball game against the Houston Astros at Globe Life Park on September 16, 2015 in Arlington, Texas. Texas won 14-3. (Photo by Brandon Wade/Getty Images)
Brandon Wade/Getty Images
Leave a comment

Tommy Stokke of RanRag Sports reports that the Braves and Rangers agreed to a trade. According to ESPN’s Keith Law, the Braves will receive pitcher Luke Jackson from the Rangers in exchange for pitchers Tyrell Jenkins and Brady Feigl.

Jackson, 25, is under team control through 2022. He has logged only 18 innings in the majors, yielding 14 runs on 22 hits and eight walks with three strikeouts. While Jackson has struggled with control, the Braves likely see upside because his fastball sits in the mid- to high-90’s.

Jenkins, 24, is also under team control through 2022. The right-hander made eight starts and six relief appearances in his first major league season in 2016, putting up a 5.88 ERA with a 26/33 K/BB ratio over 52 innings.

Feigl, 25, was an undrafted free agent and was signed by the Braves in 2013. The lefty underwent Tommy John surgery in 2015 and briefly rehabbed in rookie ball this past season.